Scarica l'app Stockscreener
7.13
1.52%
-0.11
Precedente Chiudi:
$7.24
Aprire:
$7.27
Volume 24 ore:
54,147
Relative Volume:
0.28
Capitalizzazione di mercato:
$263.62M
Reddito:
$128.45M
Utile/perdita netta:
$6.54M
Rapporto P/E:
142.60
EPS:
0.05
Flusso di cassa netto:
$-8.79M
1 W Prestazione:
-3.78%
1M Prestazione:
-14.10%
6M Prestazione:
+24.65%
1 anno Prestazione:
+42.32%
Intervallo 1D:
$7.03
$7.27
Intervallo di 1 settimana:
$7.03
$7.86
Portata 52W:
$3.6793
$8.85
Lifecore Biomedical Inc Stock (LFCR) Company Profile
Nome
Lifecore Biomedical Inc
Settore
Telefono
(952) 368-4300
Indirizzo
3515 LYMAN BOULEVARD, CHASKA
Confronta LFCR con altri titoli
| Azioni | Prezzo | Cap. di mercato | Reddito | Reddito netto | Flusso di cassa | EPS |
|---|---|---|---|---|---|---|
LFCR
Lifecore Biomedical Inc
|
7.12 | 286.21M | 128.45M | 6.54M | -8.79M | 0.05 |
|
ZTS
Zoetis Inc
|
148.77 | 64.93B | 9.39B | 2.61B | 2.22B | 5.81 |
|
TAK
Takeda Pharmaceutical Co Adr
|
14.45 | 45.07B | 29.98B | 958.27M | 5.31B | 0.2964 |
|
HLN
Haleon Plc Adr
|
9.455 | 41.52B | 14.35B | 1.85B | 0 | 0.4023 |
|
TEVA
Teva Pharmaceutical Industries Ltd Adr
|
16.41 | 18.37B | 16.54B | -1.64B | 749.00M | -1.45 |
|
UTHR
United Therapeutics Corp
|
302.54 | 13.68B | 2.99B | 1.21B | 1.13B | 25.06 |
Lifecore Biomedical Inc Stock (LFCR) Upgrades & Downgrades
| Data | Azione | Analista | Modifica della valutazione |
|---|---|---|---|
| 2025-05-21 | Iniziato | William Blair | Outperform |
| 2024-09-05 | Iniziato | Craig Hallum | Buy |
| 2024-08-28 | Downgrade | Barrington Research | Outperform → Mkt Perform |
| 2023-03-20 | Downgrade | Stephens | Overweight → Equal-Weight |
Lifecore Biomedical Inc Borsa (LFCR) Ultime notizie
Lifecore Biomedical, Inc. (LFCR) Investigation: Bronstein, Gewirtz & Grossman, LLC Encourages Investors to Seek Compensation for Alleged Wrongdoings - ACCESS Newswire
Lifecore Biomedical Full Year 2025 Earnings: EPS Beats Expectations - Yahoo Finance
Using Ichimoku Cloud for Lifecore Biomedical Inc. technicalsFree Step-by-Step Stock Investment Guide - Newser
Custom strategy builders for tracking Lifecore Biomedical Inc.Free Profit Target Stock Opportunity Monitor - Newser
Lifecore Biomedical 2025 Q4 Earnings Significant Net Loss Improvement - AInvest
Lifecore (LFCR) Q4 Revenue Beats 3% - AOL.com
Lifecore Biomedical: Navigating Headwinds with Strategic Resilience and Long-Term Growth Catalysts - AInvest
Lifecore Biomedical's Q4 2025: Unpacking Key Contradictions on Tariffs, Demand, and Market Growth - AInvest
The one-year returns have been decent for Lifecore Biomedical (NASDAQ:LFCR) shareholders despite underlying losses increasing - simplywall.st
Earnings call transcript: Lifecore Biomedical Q4 2025 sees stock rise despite EPS miss - Investing.com Nigeria
Earnings call transcript: Lifecore Biomedical Q4 2025 sees stock rise despite EPS miss By Investing.com - Investing.com South Africa
Lifecore Biomedical Reports Fourth Quarter and Fiscal Year 2025 Financial Results and Provides Corporate Update - GlobeNewswire
Lifecore Biomedical: Fiscal Q4 Earnings Snapshot - Milford Mirror
Lifecore Biomedical Inc reports results for the quarter ended May 31Earnings Summary - TradingView
Transcript : Lifecore Biomedical, Inc., Q4 2025 Earnings Call, Aug 07, 2025 - MarketScreener
Signal strength of Lifecore Biomedical Inc. stock in tech scannersPredictable Income Summary for Long-Term Trades - Newser
Lifecore Biomedical (LFCR) Reports Q4 Loss, Tops Revenue Estimates - sharewise.com
Lifecore Biomedical’s Strong Financial Performance and Strategic Initiatives Justify Buy Rating - TipRanks
Lifecore Biomedical earnings missed by $0.02, revenue topped estimates - Investing.com Canada
Lifecore Biomedical reports $128.9mln FY25 revenue, meets full-year guidance. - AInvest
Lifecore Biomedical Reports Q4 and FY25 Financial Results, Achieves Full-Year Guidance, and Provides Corporate Update - AInvest
Laughing Water Capital's Top 5 Holdings for Q2 2025 - AInvest
Laughing Water Capital's Top 5 Positions For Q2 2025 - Seeking Alpha
Lifecore Biomedical Reports 2025 Financial Results - TipRanks
Short interest data insights for Lifecore Biomedical Inc.Risk Balanced Picks for Safer Trading - Newser
Momentum divergence signals in Lifecore Biomedical Inc. chartFree Early Entry Tips With Low Risk Zone - Newser
How hedge fund analytics apply to Lifecore Biomedical Inc. stockBreakout Monitoring with Momentum Analysis - Newser
Ranking Lifecore Biomedical Inc. among high performing stocks via toolsPortfolio Review Summary with Five-Year Outlook - Newser
Can Lifecore Biomedical Inc. stock recover from recent declineDay Trading Setup Forecast with Trend Model - Newser
Lifecore Biomedical Inc expected to post a loss of 9 cents a shareEarnings Preview - TradingView
Should you hold or exit Lifecore Biomedical Inc. nowWeekly Stock Movement Prediction Watchlist - Newser
Lifecore Biomedical Inc. Stock Chart Analysis: Bullish or Bearish Pattern FormingFree Weekly Watchlist of High Movers - Newser
What drives Lifecore Biomedical Inc. stock priceBuild a diversified portfolio for stability - Jammu Links News
What catalysts could drive Lifecore Biomedical Inc. stock higher in 2025Rapid return acceleration - Jammu Links News
What institutional investors are buying Lifecore Biomedical Inc. stockInvest confidently with professional market insights - Jammu Links News
What is the risk reward ratio of investing in Lifecore Biomedical Inc. stockInvest smarter with actionable stock recommendations - Jammu Links News
When is Lifecore Biomedical Inc. stock expected to show significant growthAchieve remarkable returns with smart investing - Jammu Links News
Is it the right time to buy Lifecore Biomedical Inc. stockCapitalize on momentum stocks early - Jammu Links News
What is the dividend policy of Lifecore Biomedical Inc. stockMassive profits - Jammu Links News
What are analysts’ price targets for Lifecore Biomedical Inc. in the next 12 monthsConsistently outstanding ROI - Jammu Links News
Why is Lifecore Biomedical Inc. stock attracting strong analyst attentionInvest confidently with market-leading analysis - Jammu Links News
Will Lifecore Biomedical Inc. stock go up soonTrade Safety Matrix for Conservative Traders - Newser
Is Lifecore Biomedical Inc. stock a good hedge against inflationScalable Strategy with Chart Confirmation - Newser
Published on: 2025-07-31 22:42:45 - Newser
Lifecore Biomedical Inc Azioni (LFCR) Dati Finanziari
Reddito
Reddito netto
Flusso di cassa
EPS
Lifecore Biomedical Inc Azioni (LFCR) insider trading
| Commercio interno | Relazione | Data | Transazione | Costo | #Azioni | Valore ($) | #Azioni Totale |
|---|---|---|---|---|---|---|---|
| English Aron R. | 10% Owner |
May 28 '25 |
Sale |
7.12 |
150,419 |
1,071,555 |
264,180 |
| English Aron R. | 10% Owner |
May 23 '25 |
Sale |
6.75 |
96,137 |
649,386 |
1,554,103 |
| English Aron R. | 10% Owner |
May 13 '25 |
Sale |
7.00 |
12,334 |
86,353 |
1,650,240 |
| English Aron R. | 10% Owner |
May 12 '25 |
Sale |
7.03 |
45,698 |
321,426 |
1,662,574 |
| English Aron R. | 10% Owner |
May 08 '25 |
Sale |
7.00 |
5,098 |
35,693 |
1,708,972 |
| English Aron R. | 10% Owner |
May 09 '25 |
Sale |
7.00 |
700 |
4,900 |
1,708,272 |
| English Aron R. | 10% Owner |
May 05 '25 |
Sale |
7.08 |
24,543 |
173,831 |
1,730,618 |
| English Aron R. | 10% Owner |
May 07 '25 |
Sale |
7.01 |
15,847 |
111,099 |
1,714,070 |
| English Aron R. | 10% Owner |
May 06 '25 |
Sale |
7.05 |
701 |
4,940 |
1,729,917 |
| Josephs Paul | Chief Executive Officer |
Jan 08 '25 |
Buy |
5.74 |
17,000 |
97,580 |
559,717 |
0.56%
3.09%
Apri su Yahoo
|
Apri su Google
|
Aperto in Finviz
|
Apri in MarketWatch
|
Aperto a EDGAR
|
Aperto su Reuters
Capitalizzazione:
|
Volume (24 ore):